NASDAQ: HYPD
Hyperion Defi Inc Stock

$14.36-1.46 (-9.23%)
Updated Jul 3, 2025
HYPD Price
$14.36
Fair Value Price
-$12.30
Market Cap
$41.40M
52 Week Low
$0.85
52 Week High
$124.80
P/E
-0.32x
P/B
-4.26x
P/S
35.9x
PEG
N/A
Dividend Yield
N/A
Revenue
$67.06k
Earnings
-$42.38M
Gross Margin
-5,453.4%
Operating Margin
-59,634.36%
Profit Margin
-63,194.1%
Debt to Equity
-1.62
Operating Cash Flow
-$25M
Beta
1.04
Next Earnings
N/A
Ex-Dividend
N/A
Next Dividend
N/A

HYPD Overview

A U.S.-based firm pivoting from ophthalmic drug-delivery tech (Optejet) to becoming the first Nasdaq-listed U.S. company with a cryptocurrency treasury denominated in HYPE tokens from the Hyperliquid blockchain; also operates a validator (“Kinetiq × Hyperion”) and continues DeFi staking strategies alongside ongoing development of Optejet UFD™ for eye care.

Zen Rating

Our proven quant model uses 115 proprietary factors, including AI, to determine HYPD's potential to beat the market

Zen Rating Component Grades

N/A
Zen Rating uses advanced AI algorithms that detect subtle patterns in market data; it anticipates future trends that point to superior stock price results.

Industry: Biotech

Industry Rating
F
HYPD
Ranked
Unranked of 468

Top Ranked Stocks in Industry

View Top Biotech Stocks

Be the first to know about important HYPD news, forecast changes, insider trades & much more!

HYPD News

Overview

Due Diligence Score

Industry Average (24)
You've viewed Due Diligence Score for 10/10 free stocks. Upgrade to Premium to see how HYPD scored across 33 valuation, financial, forecast, performance, and dividend due diligence checks.

Due Diligence Checks

HYPD ($14.36) is overvalued by 216.75% relative to our estimate of its Fair Value price of -$12.30 based on Discounted Cash Flow (DCF) modelling
Below Fair Value Valuation
HYPD ($14.36) is not significantly undervalued (216.75%) relative to our estimate of its Fair Value price of -$12.30 based on Discounted Cash Flow (DCF) modelling, when including a healthy margin of safety
Significantly Below Fair Value Valuation
HYPD is unprofitable, so we... subscribe to Premium to read more.
Below Benjamin Graham Formula Value Valuation
There are 30 more HYPD due diligence checks available for Premium users.

Valuation

HYPD fair value

Fair Value of HYPD stock based on Discounted Cash Flow (DCF)

Price
$14.36
Fair Value
-$12.30
Undervalued by
216.75%
HYPD ($14.36) is overvalued by... subscribe to Premium to read more.
Below Fair Value Valuation
HYPD ($14.36) is not significantly... subscribe to Premium to read more.
Significantly Below Fair Value Valuation
HYPD is unprofitable, so we... subscribe to Premium to read more.
Below Benjamin Graham Formula Value Valuation

HYPD price to earnings (PE)

For valuing profitable companies with steady earnings

Company
-0.32x
Industry
-154.26x
Market
30.96x

HYPD price to book (PB)

For valuing companies that are loss-making or have lots of physical asset

Company
-4.26x
Industry
4.54x

HYPD's financial health

Profit margin

Revenue
$14.7k
Net Income
-$3.5M
Profit Margin
-23,665.3%
HYPD's cash and short-term investments... subscribe to Premium to read more.
Interest Coverage Financials
HYPD's profit margin has increased... subscribe to Premium to read more.
Profit Margin Growth Financials

Assets to liabilities

Assets
$6.0M
Liabilities
$15.7M
Debt to equity
-1.62
HYPD's short-term liabilities ($15.10M) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
HYPD's short-term assets ($5.16M) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
HYPD's debt relative to shareholder... subscribe to Premium to read more.
Shrinking Debt Financials
HYPD's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials

Cash flow

Operating
-$4.4M
Investing
$0.0
Financing
$6.3M
HYPD's cash and short-term investments... subscribe to Premium to read more.
Debt Coverage Financials

HYPD vs Biotech Stocks

TickerZen RatingMarket Cap1d %P/EP/B
HYPD$41.40M-20.75%-0.32x-4.26x
ACRVD$40.45M-3.10%-0.58x0.25x
XCUR$42.83M-4.57%-1.77x3.76x
PEPGF$39.92M-9.02%-0.39x0.43x
STTK$39.90M-7.32%-0.60x0.59x

Hyperion Defi Stock FAQ

What is Hyperion Defi's quote symbol?

(NASDAQ: HYPD) Hyperion Defi trades on the NASDAQ under the ticker symbol HYPD. Hyperion Defi stock quotes can also be displayed as NASDAQ: HYPD.

If you're new to stock investing, here's how to buy Hyperion Defi stock.

What is the 52 week high and low for Hyperion Defi (NASDAQ: HYPD)?

(NASDAQ: HYPD) Hyperion Defi's 52-week high was $124.80, and its 52-week low was $0.85. It is currently -88.49% from its 52-week high and 1,589.41% from its 52-week low.

How much is Hyperion Defi stock worth today?

(NASDAQ: HYPD) Hyperion Defi currently has 2,882,808 outstanding shares. With Hyperion Defi stock trading at $14.36 per share, the total value of Hyperion Defi stock (market capitalization) is $41.40M.

Hyperion Defi stock was originally listed at a price of $793.60 in Jan 25, 2018. If you had invested in Hyperion Defi stock at $793.60, your return over the last 7 years would have been -98.19%, for an annualized return of -43.63% (not including any dividends or dividend reinvestments).

How much is Hyperion Defi's stock price per share?

(NASDAQ: HYPD) Hyperion Defi stock price per share is $14.36 today (as of Jul 3, 2025).

What is Hyperion Defi's Market Cap?

(NASDAQ: HYPD) Hyperion Defi's market cap is $41.40M, as of Jul 8, 2025.

Market cap (market capitalization) is the total market value of a publicly traded company's outstanding shares.

Hyperion Defi's market cap is calculated by multiplying HYPD's current stock price of $14.36 by HYPD's total outstanding shares of 2,882,808.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.